Physician profile
Alysaa A Phyars
NPI 1952743262
$3,936.31
in general payments reported to CMS, 2019-2025
23 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $205 · 2021: $415 · 2022: $306 · 2023: $2,052 · 2024: $601 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,505 · Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,505.20 |
| Food and Beverage | $1,316.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,529.07 | 2023 | |
| Novo Nordisk INC | $509.12 | 2019-2023 | Rybelsus, Ozempic |
| Abbott Laboratories | $450.17 | 2021-2025 | Freestyle Libre 3 |
| Organogenesis INC. | $308.48 | 2019-2024 | Puraply, Affinity |
| Smith+Nephew, INC. | $287.67 | 2019-2024 | Collagenase Santyl, Regranex, Grafix Pl |
| Nevro Corp. | $112.44 | 2024 | Senza |
| Averitas Pharma INC. | $102.41 | 2023-2024 | Qutenza |
| Ibsa Pharma INC. | $85.74 | 2023-2025 | Tirosint, Licart, Tirosint |
| Advanced Oxygen Therapy INC. | $79.46 | 2021-2023 | Topical Oxygen Chamber For Extremities |
| Amgen INC. | $69.40 | 2021-2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $62.37 | 2022-2025 | |
| Melinta Therapeutics, LLC | $58.80 | 2019 | |
| Paratek Pharmaceuticals, INC. | $34.39 | 2025 | Nuzyra |
| Amryt Pharma Holdings LTD | $33.99 | 2021-2023 | Mycapssa |
| Abbvie INC. | $33.22 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $30.07 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.77 | 2025 | |
| Becton, Dickinson and Company | $27.11 | 2021-2022 | |
| Misonix INC | $22.55 | 2020 | |
| Globus Medical, INC. | $21.49 | 2025 | Senza |
| Kerecis Limited | $19.67 | 2022 | |
| Amarin Pharma, INC. | $17.35 | 2020 | |
| Antares Pharma, INC. | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alysaa Phyars listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.